C. Sonaglio

Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer

Carmelo Bengala, Stefania Bettelli, Federica Bertolini et al. · Annals of Oncology · 2008 · 90 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Neoadjuvant Treatment With Single-Agent Cetuximab Followed by 5-FU, Cetuximab, and Pelvic Radiotherapy: A Phase II Study in Locally Advanced Rectal Cancer

Federica Bertolini, Silvana Chiara, Carmelo Bengala et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 84 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia

Fortunato Morabito, Giovanna Cutrona, Massimo Gentile et al. · British Journal of Haematology · 2009 · 55 citations · Full text

Medicine, Hematology, Oncology +16

Low Percentage of KRAS Mutations Revealed by Locked Nucleic Acid Polymerase Chain Reaction: Implications for Treatment of Metastatic Colorectal Cancer

Mariella Dono, Carlotta Massucco, Silvana Chiara et al. · Molecular Medicine · 2012 · 28 citations · Full text

Medicine, Molecular Genetics, Oncology +16

A Randomized Phase III Study Evaluating the Continuation of Bevacizumab (BV) Beyond Progression in Metastatic Colorectal Cancer (MCRC) Patients (PTS) Who Received BV as Part of First-Line Treatment: Results of the Bebyp Trial by the Gruppo Oncologico Nord Ovest (GONO)

Gianluca Masi, Fotios Loupakis, Lisa Salvatore et al. · Annals of Oncology · 2012 · 24 citations

Medicine, Oncology, Pharmacotherapy +9